EBNENM – European Board in Neuroendocrine Neoplasia Medicine
Welcome to the European Board of Neuroendocrine Neoplasia Medicine.
The EBNENM programme sets a European standard for education, training and certification in neuroendocrine neoplasia (NEN) medicine. It aims to promote excellence, harmonise training pathways and support high-quality multidisciplinary care across Europe.
Continuous medical education makes a difference!
ENETS has expanded its educational portfolio to include the European Board in Neuroendocrine Neoplasia Medicine (EBNENM), developed jointly with UEMS. Our vision is to serve patients, physicians and scientists across the European Union by providing postgraduate medical education and training of the highest quality in the field of NEN medicine.
Whether you are a prospective trainee, trainer, or training institution, we invite you to explore this opportunity and learn more about the EBNENM programme.
What is EBNENM?
European certification programme defining standards for postgraduate training and certification in neuroendocrine neoplasia medicine.
Why get certified?
Demonstrates specialist competence and supports European recognition and harmonised training standards.
Who can apply?
Qualified physicians with relevant postgraduate training and clinical experience in neuroendocrine neoplasia medicine.
Key dates 2026
- Exam application deadline: 3 February 2026, 23:59 CET
- Written exam: 4 March 2026, during ENETS 2026 in Kraków, Poland
- Oral exam: 5 or 6 March 2026, during ENETS 2026 in Kraków, Poland